We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants
TCBPW

Delisted

TCBPW was delisted on the 21st of March, 2025.

Back to rankings

6 hedge funds and large institutions have $14.2K invested in TC BioPharm (Holdings) plc Warrants in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $14.1K → $14.2K (+$88)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$11.6K
2
CAG
Csenge Advisory Group
Florida
+$87
3
UBS Group
UBS Group
Switzerland
+$21
4
AC
Armistice Capital
New York
+$3

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$343
2
Bank of America
Bank of America
North Carolina
-$1

TCBPW Hedge Fund Activity: Q4 2024 in Review

6 of the 7,609 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2024, worth a combined $14.2K — up 0.62% from $14.1K a quarter earlier.

Fund positioning in TCBPW was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $11.6K. The largest seller was Altium Capital Management, exiting entirely with an estimated $343 sold.

  • 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $14.2K of TC BioPharm (Holdings) plc Warrants stock for Q4 2024, up 0.62% quarter-over-quarter.
  • 2 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2024 and 2 closed out, a net change of 0 holders.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q4 2024 was Wolverine Asset Management, an estimated $11.6K added.
  • The largest TC BioPharm (Holdings) plc Warrants seller in Q4 2024 was Altium Capital Management, an estimated $343 sold.

Based on aggregated 13F filings for Q4 2024.